Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
<< anterior 21 a 40 de 141 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Fazel M. Methylphenidate for ADHD. BMJ 2015;351:h5875. [Ref.ID 99702]
22. Cita con resumen
Anónimo. Flibanserin (Addyi) for hypoactive sexual desire disorder. Med Lett Drugs Ther 2015;57:133-5. [Ref.ID 99654]
23. Cita con resumen
Gellad WF, Flynn KE, Alexander C. Evaluation of flibanserin: science and advocacy at the FDA. JAMA 2015;314:869-70. [Ref.ID 99515]
24. Cita con resumen
Pozzi M. Valeant compra la compañía del "Viagra femenino". El País 2015:21. [Ref.ID 99415]
25. Cita con resumen
Herman AO. FDA approves drug for hypoactive sexual desire disorder in women. Journal Watch 2015:1. [Ref.ID 99407]
26. Cita con resumen
Young K. FDA advisers back approval of first drug for female sexual dysfunction. Journal Watch 2015:1. [Ref.ID 99241]
27.Tiene citas relacionadas Cita con resumen
Roehr B. FDA committee recommends approval for “female Viagra”. BMJ 2015;350:h3097. [Ref.ID 99189]
28. Cita con resumen
Colorectal Writing Group for the Surgical Care and Outcomes Assessment Program–Comparative Effectiveness Research Translation Network (SCOAP-CERTAIN) Collaborative. Thromboembolic complications and prophylaxis patterns in colorectal surgery. JAMA Surgery 2015;150:712-20. [Ref.ID 99173]
29. Cita con resumen
Anónimo. FDA approves two drugs for treatment of IBS with diarrhea. DIA Daily 2015:28 de mayo. [Ref.ID 99106]
30. Cita con resumen
Anónimo. FDA grants marketing approval to double chin injection. DIA Daily 2015:30 de abril. [Ref.ID 99020]
31. Cita con resumen
Anónimo. Drugs for ADHD. Med Lett Drugs Ther 2015;57:37-40. [Ref.ID 98882]
32. Cita con resumen
Moynihan R. Evening the score on sex drugs: feminist movement or marketing masquerade?. BMJ 2014;349:g6246. [Ref.ID 98287]
33. Cita con resumen
Schwarz A. Idea of new attention disorder spurs research, and debate. N Y Times (Print) 2014:11 de abril. [Ref.ID 97394]
34. Cita con resumen
Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, Ferguson N, Goonetilleke N, Harvey G, Kovar J, Lim MSC, McMichael A, Millett ERC, Nguyen-Van-Tam JS, Nazareth I, Pebody R, Tabassum F, Watson JM, Wurie FB, Johnson AM, Zambon M, on behalf of the Flu Watch Group. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. The Lancet Respiratory Medicine 2014;2:445-54. [Ref.ID 97225]
35. Cita con resumen
Spence D. Bad medicine: restless legs syndrome. BMJ 2013;347:f7615. [Ref.ID 97178]
36. Cita con resumen
Moynihan R. Act now to fight chronic procrastination disorder. BMJ 2013;347:24. [Ref.ID 96475]
37. Cita con resumen
Anónimo. FDA permits marketing of first brain wave test to help assess children and teens for ADHD. U.S. Food and Drug Administration 2013:15 de julio. [Ref.ID 95705]
38.Tiene citas relacionadas Cita con resumen
Schwartz A, Cohen S. A.D.H.D. seen in 11% of U.S. children as diagnoses rise. N Y Times (Print) 2013:31 de marzo. [Ref.ID 95134]
39. Cita con resumen
Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, Mazer MA, Knapp PE, Hanka S, Lakshman KM, Ulloor J, Zhang A, Orwoll K, Eder R, Collins L, Mohammed N, Rosen RC, DeRogatis L, Shasin S. Effect of testosterone replacement on response to sildenafil citrate in men with erectible dysfunction: a parallel, randomized trial. Ann Intern Med 2012;157:681-91. [Ref.ID 94088]
40. Cita con resumen
Delamothe T. Monkey business. BMJ 2012;345:29. [Ref.ID 93505]
Seleccionar todas
 
<< anterior 21 a 40 de 141 siguiente >>